With the European Commission looking to formally strengthen health technology assessment (HTA) across Member States, Leela Barham attempts to assess and benchmark the resources currently d
Pharma has much to gain from leveraging components of a virtual business model, especially as an innovative way to work with experts and partners at the right moments throughout the product lif
In the pharma industry, companies need to know where products are at any point in the supply chain, but with one of the most complex systems of any industry, what are the pressure points and how can they be managed?
In the latest edition of our Deep Dive magazine - Deep Dive: Patient Centricity II - David Mitchell, President of Patients For Affordable Drugs, speaks to pharmaphorum’s Andrew McConaghie about why the organisation was set up and why its campaigning work is so important for patients.
A survey of small-to-medium pharma companies in the UK has revealed seven out of ten have “little or no confidence” in the government’s handling of Brexit negotiations, and nearly two-thirds be
